Nu Skin Enterprises (NUS) Misses Q3 EPS by 12c
Tweet
Share
E-mail
Get Alerts NUS Hot Sheet
Price: $4.84 +2.98%
Revenue Growth %: +3.1%
Financial Fact:
Basic (in shares): 55.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.1%
Financial Fact:
Basic (in shares): 55.98M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.47, $0.12 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $537.8 million versus the consensus estimate of $576.28 million.
GUIDANCE:
Nu Skin Enterprises sees FY2022 EPS of $2.60. Nu Skin Enterprises sees FY2022 revenue of $2.2-2.25 billion, versus the consensus of $2.36 billion.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
